<DOC>
	<DOCNO>NCT02622685</DOCNO>
	<brief_summary>The purpose study evaluate safety , tolerability , pharmacokinetics pharmacodynamics DWP10292 UDCA healthy male volunteer multiple-dosing .</brief_summary>
	<brief_title>A Multiple Dose Study DWP10292 UDCA Healthy Male Subjects</brief_title>
	<detailed_description>This study dose block-randomized , double-blind , placebo control , multiple-dosing , dose escalation clinical trial investigate safety , tolerability pharmacokinetic characteristic DWP 10292 oral administration healthy male subject .</detailed_description>
	<mesh_term>Ursodeoxycholic Acid</mesh_term>
	<criteria>A subject provide write informed consent participate study cooperative regard compliance study related constraint Healthy adult male subject age 19 45 year The subject Body weight ≥ 60 kg &lt; 90 kg Body Mass Index ( BMI ) ≥ 18.5 kg/m2 &lt; 27.0 kg/m2 A Subject judge healthy investigator participate study base screen result ( accord standard reference index update recently ) A subject sign symptom previously diagnose disease liver ( viral hepatitis ) , digestive system , cardiovascular , kidney , respiratory , endocrinology , neurology , immune system , hematology , psychology function significant diseases history suspicion current drug abuse alcohol abuse A subject show vital sign number systolic blood pressure ≥140 mmHg ≤100 mmHg , number diastolic blood pressure ≥90mmHg ≤60mmHg A subject donates blood ( whole blood donation within last 2 month plasma donation within last 1 month ) receive blood transfusion within last 1 month Subject take clinical licensed medication another clinical trial within 3month period prior first administration study medication ( The last administration medication consider end point previous clinical trial ) Subject smoke average 10 cigarettes/day unable quit smoke clinical trial</criteria>
	<gender>Male</gender>
	<minimum_age>19 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>